Symbols / NAII Stock $2.71 +1.31% Natural Alternatives International, Inc.

Consumer Defensive • Packaged Foods • United States • NGM
NAII (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Packaged Foods
CEO Mr. Mark A. LeDoux J.D.
Exch · Country NGM · United States
Market Cap 16.74M
Enterprise Value 74.22M
Income -12.25M
Sales 135.16M
FCF (ttm) 108.50K
Book/sh 11.17
Cash/sh 0.62
Employees 293
Insider 10d —
IPO Oct 28, 1993
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG 5.41
P/S 0.12
P/B 0.24
P/C —
EV/EBITDA 175.05
EV/Sales 0.55
Quick Ratio 0.66
Current Ratio 1.87
Debt/Eq 92.04
LT Debt/Eq —
EPS (ttm) -2.05
EPS next Y —
EPS Growth —
Revenue Growth 2.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2025-09-29
Earnings (prior) 2025-09-29
ROA -1.70%
ROE -16.75%
ROIC —
Gross Margin 9.06%
Oper. Margin -5.31%
Profit Margin -9.06%
Shs Outstand 6.18M
Shs Float 4.36M
Insider Own 22.03%
Instit Own 36.21%
Short Float 0.11%
Short Ratio 0.16
Short Interest 5.26K
52W High 4.96
vs 52W High -45.36%
52W Low 2.33
vs 52W Low 16.31%
Beta 0.39
Impl. Vol. —
Rel Volume 2.38
Avg Volume 25.78K
Volume 61.41K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $2.67
Price $2.71
Change 1.31%
About

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$2.71
Latest analyst target
3. DCF / Fair value
$0.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.71
Low
—
High
—
Mean
—
News
RSS: Latest NAII news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-06 WOLF KENNETH EUGENE President — 15,000 $0.00 $0
2026-03-06 RAMANATHAN GURU P Director — 8,000 $0.00 $0
2026-03-06 FORTIN MICHAEL E. Chief Financial Officer — 12,000 $0.00 $0
2026-03-06 MATHERLY LAURA KAY Director — 8,000 $0.00 $0
2026-03-06 LEDOUX MARK A Chief Executive Officer — 1,250 $2.75 $3,474
2026-03-06 LEDOUX MARK A Chief Executive Officer — 20,000 $0.00 $0
2026-03-06 DUNN ALAN G Director — 8,000 $0.00 $0
2026-03-02 LEDOUX MARK A Chief Executive Officer — 1,000 $2.79 $2,820
2026-02-27 LEDOUX MARK A Chief Executive Officer — 1,250 $2.80 $3,528
2026-02-24 LEDOUX MARK A Chief Executive Officer — 2,000 $2.66 $5,399
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
129.86
+14.12%
113.80
-26.11%
154.01
-9.91%
170.97
Operating Revenue
129.86
+14.12%
113.80
-26.11%
154.01
-9.91%
170.97
Cost Of Revenue
120.57
+12.76%
106.93
-21.29%
135.86
-3.28%
140.46
Reconciled Cost Of Revenue
120.57
+12.76%
106.93
-21.29%
135.86
-3.28%
140.46
Gross Profit
9.29
+35.31%
6.87
-62.19%
18.16
-40.48%
30.51
Operating Expense
16.55
+7.47%
15.40
+14.53%
13.45
-20.11%
16.83
Selling General And Administration
16.55
+7.47%
15.40
+3.56%
14.87
-12.28%
16.95
Total Expenses
137.12
+12.09%
122.33
-18.07%
149.30
-5.08%
157.29
Operating Income
-7.26
+14.93%
-8.53
-281.07%
4.71
-65.55%
13.68
Total Operating Income As Reported
-8.66
-1.48%
-8.53
-281.07%
4.71
-65.55%
13.68
EBITDA
-5.26
-18.16%
-4.46
-153.97%
8.26
-53.90%
17.91
Normalized EBITDA
-2.52
+33.62%
-3.80
-142.67%
8.91
-49.89%
17.79
Reconciled Depreciation
4.56
-1.87%
4.65
+9.34%
4.25
+2.04%
4.17
EBIT
-9.82
-7.93%
-9.10
-327.23%
4.01
-70.85%
13.74
Total Unusual Items
-2.74
-320.25%
-0.65
+0.91%
-0.66
-657.63%
0.12
Total Unusual Items Excluding Goodwill
-2.74
-320.25%
-0.65
+0.91%
-0.66
-657.63%
0.12
Special Income Charges
-1.40
0.00
—
—
Other Special Charges
1.40
—
—
—
Net Income
-13.57
-88.10%
-7.22
-386.16%
2.52
-76.46%
10.71
Pretax Income
-10.74
-13.48%
-9.46
-366.22%
3.56
-73.97%
13.66
Net Non Operating Interest Income Expense
-0.75
-303.78%
-0.18
+55.74%
-0.42
-403.61%
-0.08
Interest Expense Non Operating
0.92
+153.46%
0.36
-19.96%
0.45
+443.37%
0.08
Net Interest Income
-0.75
-303.78%
-0.18
+55.74%
-0.42
-403.61%
-0.08
Interest Expense
0.92
+153.46%
0.36
-19.96%
0.45
+443.37%
0.08
Interest Income Non Operating
0.17
-4.55%
0.18
+433.33%
0.03
0.00
Interest Income
0.17
-4.55%
0.18
+433.33%
0.03
0.00
Other Income Expense
-2.73
-266.85%
-0.74
-0.68%
-0.74
-1274.60%
0.06
Other Non Operating Income Expenses
0.01
+107.53%
-0.09
-13.41%
-0.08
-49.09%
-0.06
Gain On Sale Of Security
-1.34
-105.52%
-0.65
+0.91%
-0.66
-657.63%
0.12
Tax Provision
2.83
+226.17%
-2.25
-317.52%
1.03
-64.95%
2.95
Tax Rate For Calcs
0.00
-11.39%
0.00
-18.56%
0.00
+34.72%
0.00
Tax Effect Of Unusual Items
-0.58
-272.37%
-0.15
+19.30%
-0.19
-851.25%
0.03
Net Income Including Noncontrolling Interests
-13.57
-88.10%
-7.22
-386.16%
2.52
-76.46%
10.71
Net Income From Continuing Operation Net Minority Interest
-13.57
-88.10%
-7.22
-386.16%
2.52
-76.46%
10.71
Net Income From Continuing And Discontinued Operation
-13.57
-88.10%
-7.22
-386.16%
2.52
-76.46%
10.71
Net Income Continuous Operations
-13.57
-88.10%
-7.22
-386.16%
2.52
-76.46%
10.71
Normalized Income
-11.41
-69.81%
-6.72
-324.84%
2.99
-71.86%
10.62
Net Income Common Stockholders
-13.57
-88.10%
-7.22
-386.16%
2.52
-76.46%
10.71
Diluted EPS
-2.28
-85.37%
-1.23
-386.05%
0.43
-75.29%
1.74
Basic EPS
-2.28
-85.37%
-1.23
-386.05%
0.43
-75.43%
1.75
Basic Average Shares
5.95
+1.29%
5.87
+0.13%
5.86
-4.15%
6.12
Diluted Average Shares
5.95
+1.29%
5.87
-0.11%
5.88
-4.51%
6.16
Diluted NI Availto Com Stockholders
-13.57
-88.10%
-7.22
-386.16%
2.52
-76.46%
10.71
Provision For Doubtful Accounts
—
0.00
+100.00%
-1.42
-1086.67%
-0.12
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
151.94
-6.41%
162.34
+21.01%
134.15
-8.12%
146.00
Current Assets
59.28
-3.79%
61.61
+8.07%
57.01
-25.72%
76.75
Cash Cash Equivalents And Short Term Investments
12.32
+2.87%
11.98
-11.93%
13.60
-37.69%
21.83
Cash And Cash Equivalents
12.32
+2.87%
11.98
-11.93%
13.60
-37.69%
21.83
Receivables
14.92
-11.67%
16.89
+130.53%
7.33
-58.11%
17.49
Accounts Receivable
14.64
-13.30%
16.89
+140.54%
7.02
-59.69%
17.42
Gross Accounts Receivable
14.64
-13.30%
16.89
+139.76%
7.04
-66.14%
20.80
Allowance For Doubtful Accounts Receivable
0.00
0.00
+100.00%
-0.02
+99.32%
-3.38
Taxes Receivable
0.28
0.00
-100.00%
0.30
+355.22%
0.07
Inventory
24.87
+2.57%
24.25
-18.34%
29.69
-8.56%
32.48
Raw Materials
17.63
-4.64%
18.49
-11.73%
20.95
-25.71%
28.20
Work In Process
3.94
+17.28%
3.36
-25.36%
4.50
+131.21%
1.95
Finished Goods
4.05
+33.44%
3.04
-38.35%
4.93
+73.40%
2.84
Prepaid Assets
—
—
—
1.80
Hedging Assets Current
0.37
-25.20%
0.49
+26.15%
0.39
-87.60%
3.14
Other Current Assets
6.79
-15.07%
8.00
+33.39%
6.00
+232.13%
1.80
Total Non Current Assets
92.66
-8.01%
100.73
+30.58%
77.14
+11.39%
69.26
Net PPE
91.94
-3.97%
95.75
+29.02%
74.21
+11.97%
66.27
Gross PPE
147.92
-2.08%
151.06
+20.97%
124.87
+8.87%
114.70
Accumulated Depreciation
-55.97
-1.20%
-55.31
-9.17%
-50.66
-4.62%
-48.42
Properties
0.00
0.00
0.00
0.00
Land And Improvements
8.94
+0.00%
8.94
+0.00%
8.94
+16.94%
7.64
Buildings And Improvements
24.65
-0.30%
24.72
+0.04%
24.71
+41.90%
17.41
Machinery Furniture Equipment
48.48
-4.24%
50.63
+5.03%
48.21
+4.10%
46.31
Other Properties
41.05
-5.70%
43.54
+113.74%
20.37
-6.14%
21.70
Leases
24.79
+6.74%
23.22
+2.57%
22.64
+4.69%
21.63
Non Current Deferred Assets
0.00
-100.00%
3.17
+792.96%
0.35
0.00
Non Current Deferred Taxes Assets
0.00
-100.00%
3.17
+792.96%
0.35
0.00
Other Non Current Assets
0.72
-60.36%
1.81
-29.61%
2.58
-13.61%
2.98
Total Liabilities Net Minority Interest
83.51
+4.72%
79.75
+75.73%
45.38
-21.05%
57.48
Current Liabilities
28.80
+22.75%
23.46
+47.73%
15.88
-33.53%
23.89
Payables And Accrued Expenses
18.87
+17.25%
16.09
+52.37%
10.56
-44.84%
19.15
Payables
15.76
+19.01%
13.24
+62.48%
8.15
-50.17%
16.36
Accounts Payable
15.35
+20.50%
12.74
+63.80%
7.78
-51.94%
16.18
Current Accrued Expenses
3.10
+9.06%
2.85
+18.18%
2.41
-13.56%
2.79
Employee Benefits
0.11
-21.28%
0.14
-58.41%
0.34
-1.45%
0.34
Pensionand Other Post Retirement Benefit Plans Current
2.17
+3.97%
2.09
-6.95%
2.25
-38.85%
3.67
Total Tax Payable
0.41
-18.61%
0.51
+35.03%
0.37
+114.94%
0.17
Income Tax Payable
0.41
-18.61%
0.51
+35.03%
0.37
+114.94%
0.17
Current Debt And Capital Lease Obligation
4.43
-9.37%
4.89
+77.17%
2.76
+194.87%
0.94
Current Debt
2.21
-40.34%
3.70
+1084.62%
0.31
+3.31%
0.30
Other Current Borrowings
0.30
+3.04%
0.30
-5.13%
0.31
+3.31%
0.30
Current Capital Lease Obligation
2.23
+86.52%
1.19
-51.23%
2.45
+286.12%
0.63
Current Deferred Liabilities
1.36
+351.66%
0.30
-4.73%
0.32
+126.43%
0.14
Current Deferred Revenue
1.36
+351.66%
0.30
-4.73%
0.32
+126.43%
0.14
Other Current Liabilities
1.97
+2061.54%
0.09
—
—
Total Non Current Liabilities Net Minority Interest
54.71
-2.79%
56.28
+90.81%
29.50
-12.18%
33.59
Long Term Debt And Capital Lease Obligation
54.60
-1.45%
55.40
+96.67%
28.17
-8.85%
30.91
Long Term Debt
8.63
-3.41%
8.93
-2.95%
9.21
-3.03%
9.49
Long Term Capital Lease Obligation
45.97
-1.07%
46.47
+145.02%
18.96
-11.43%
21.41
Non Current Pension And Other Postretirement Benefit Plans
0.11
-21.28%
0.14
-58.41%
0.34
-1.45%
0.34
Tradeand Other Payables Non Current
0.00
-100.00%
0.74
-25.03%
0.99
-11.72%
1.12
Non Current Deferred Liabilities
—
—
0.00
-100.00%
1.22
Non Current Deferred Taxes Liabilities
—
—
0.00
-100.00%
1.22
Stockholders Equity
68.43
-17.15%
82.59
-6.96%
88.77
+0.28%
88.52
Common Stock Equity
68.43
-17.15%
82.59
-6.96%
88.77
+0.28%
88.52
Capital Stock
0.09
+0.00%
0.09
+2.20%
0.09
+2.25%
0.09
Common Stock
0.09
+0.00%
0.09
+2.20%
0.09
+2.25%
0.09
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
9.50
+0.25%
9.48
+1.79%
9.31
+1.34%
9.19
Ordinary Shares Number
6.18
-0.35%
6.20
+2.08%
6.07
-0.91%
6.13
Treasury Shares Number
3.33
+1.40%
3.28
+1.24%
3.24
+5.84%
3.06
Additional Paid In Capital
33.61
+2.99%
32.63
+3.81%
31.44
+3.33%
30.42
Retained Earnings
59.39
-18.60%
72.97
-9.00%
80.18
+3.25%
77.66
Gains Losses Not Affecting Retained Earnings
-1.42
-6331.82%
-0.02
+73.49%
-0.08
-104.89%
1.70
Treasury Stock
23.25
+0.77%
23.08
+0.97%
22.86
+7.04%
21.35
Other Equity Adjustments
-1.42
-6331.82%
-0.02
+73.49%
-0.08
-104.89%
1.70
Total Equity Gross Minority Interest
68.43
-17.15%
82.59
-6.96%
88.77
+0.28%
88.52
Total Capitalization
77.05
-15.81%
91.53
-6.58%
97.98
-0.04%
98.01
Working Capital
30.47
-20.12%
38.15
-7.25%
41.13
-22.19%
52.85
Invested Capital
79.26
-16.77%
95.22
-3.12%
98.29
-0.03%
98.31
Total Debt
59.03
-2.09%
60.29
+94.93%
30.93
-2.86%
31.84
Net Debt
—
0.65
—
—
Capital Lease Obligations
48.20
+1.12%
47.66
+122.58%
21.41
-2.88%
22.05
Net Tangible Assets
68.43
-17.15%
82.59
-6.96%
88.77
+0.28%
88.52
Tangible Book Value
68.43
-17.15%
82.59
-6.96%
88.77
+0.28%
88.52
Derivative Product Liabilities
—
—
—
0.00
Inventories Adjustments Allowances
-0.76
-18.44%
-0.64
+6.43%
-0.68
-33.86%
-0.51
Line Of Credit
1.90
-44.12%
3.40
0.00
—
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
5.93
+496.26%
-1.50
-121.33%
7.02
-40.85%
11.87
Cash Flow From Continuing Operating Activities
5.93
+496.26%
-1.50
-121.33%
7.02
-40.85%
11.87
Net Income From Continuing Operations
-13.57
-88.10%
-7.22
-386.16%
2.52
-76.46%
10.71
Depreciation Amortization Depletion
4.56
-1.87%
4.65
+9.34%
4.25
+2.04%
4.17
Depreciation And Amortization
4.56
-1.87%
4.65
+9.34%
4.25
+2.04%
4.17
Other Non Cash Items
8.65
+42.27%
6.08
+332.34%
1.41
-46.48%
2.63
Pension And Employee Benefit Expense
0.08
+76.09%
0.05
-43.21%
0.08
-2.41%
0.08
Stock Based Compensation
0.98
-18.58%
1.20
+18.23%
1.01
+4.86%
0.97
Provisionand Write Offof Assets
—
—
—
-0.12
Deferred Tax
3.61
+224.29%
-2.91
-198.46%
-0.97
-229.69%
0.75
Deferred Income Tax
3.61
+224.29%
-2.91
-198.46%
-0.97
-229.69%
0.75
Operating Gains Losses
0.13
+182.61%
0.05
+53.33%
0.03
-59.46%
0.07
Change In Working Capital
1.57
+146.97%
-3.35
-172.06%
-1.23
+83.44%
-7.43
Change In Receivables
2.25
+122.77%
-9.87
-183.47%
11.82
+1735.87%
0.64
Changes In Account Receivables
2.25
+122.77%
-9.87
-183.47%
11.82
+1735.87%
0.64
Change In Inventory
-0.62
-111.42%
5.45
+95.79%
2.78
+150.85%
-5.47
Change In Prepaid Assets
2.22
+239.20%
-1.60
+63.39%
-4.36
-5916.00%
0.07
Change In Payables And Accrued Expense
2.89
-43.41%
5.11
+150.97%
-10.03
-567.52%
2.15
Change In Accrued Expense
0.04
+113.19%
-0.27
+80.87%
-1.43
-56.64%
-0.91
Change In Payable
2.86
-46.95%
5.39
+162.60%
-8.61
-381.52%
3.06
Change In Account Payable
2.86
-46.95%
5.39
+162.60%
-8.61
-381.52%
3.06
Change In Other Working Capital
-0.93
-266.49%
0.56
-19.16%
0.69
+53.88%
0.45
Change In Other Current Assets
—
—
0.86
+137.97%
-2.27
Change In Other Current Liabilities
-4.24
-41.03%
-3.00
-40.72%
-2.13
+29.03%
-3.01
Investing Cash Flow
-3.61
-19.79%
-3.02
+77.60%
-13.47
+49.10%
-26.46
Cash Flow From Continuing Investing Activities
-3.61
-19.79%
-3.02
+77.60%
-13.47
+49.10%
-26.46
Net PPE Purchase And Sale
-3.61
-19.79%
-3.02
+77.60%
-13.47
+49.10%
-26.46
Purchase Of PPE
-3.61
-19.79%
-3.02
+77.69%
-13.52
+48.94%
-26.49
Sale Of PPE
—
0.00
-100.00%
0.06
+90.00%
0.03
Capital Expenditure
-3.61
-19.79%
-3.02
+77.69%
-13.52
+48.94%
-26.49
Financing Cash Flow
-1.97
-168.28%
2.89
+262.32%
-1.78
-141.50%
4.29
Cash Flow From Continuing Financing Activities
-1.97
-168.28%
2.89
+262.32%
-1.78
-141.50%
4.29
Net Issuance Payments Of Debt
-1.80
-157.71%
3.11
+1219.42%
-0.28
-102.84%
9.79
Issuance Of Debt
—
3.40
0.00
-100.00%
10.00
Repayment Of Debt
-0.30
-2.78%
-0.29
-3.60%
-0.28
-35.61%
-0.20
Long Term Debt Issuance
—
—
0.00
-100.00%
10.00
Long Term Debt Payments
-0.30
-2.78%
-0.29
-3.60%
-0.28
-35.61%
-0.20
Net Long Term Debt Issuance
-0.30
-2.78%
-0.29
-3.60%
-0.28
-102.84%
9.79
Short Term Debt Issuance
—
3.40
0.00
—
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
-1.50
-144.12%
3.40
0.00
0.00
Net Common Stock Issuance
-0.18
+19.46%
-0.22
+85.30%
-1.50
+72.69%
-5.50
Common Stock Payments
-0.18
+19.46%
-0.22
+85.30%
-1.50
+72.69%
-5.50
Repurchase Of Capital Stock
-0.18
+19.46%
-0.22
+85.30%
-1.50
+72.69%
-5.50
Proceeds From Stock Option Exercised
—
—
—
0.00
Changes In Cash
0.34
+121.20%
-1.62
+80.28%
-8.23
+20.11%
-10.30
Beginning Cash Position
11.98
-11.93%
13.60
-37.69%
21.83
-32.05%
32.13
End Cash Position
12.32
+2.87%
11.98
-11.93%
13.60
-37.69%
21.83
Free Cash Flow
2.32
+151.35%
-4.51
+30.61%
-6.50
+55.51%
-14.62
Interest Paid Supplemental Data
0.81
+185.61%
0.28
-64.46%
0.80
+289.32%
0.21
Income Tax Paid Supplemental Data
0.32
-30.24%
0.46
-74.86%
1.84
-29.37%
2.61
Common Stock Issuance
—
—
—
—
Issuance Of Capital Stock
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category